Liposomal Nanovaccine Containing α-Galactosylceramide and Ganglioside GM3 Stimulates Robust CD8+ T Cell Responses via CD169+ Macrophages and cDC1

Liposomal Nanovaccine Containing α-Galactosylceramide and Ganglioside GM3 Stimulates Robust CD8+ T Cell Responses via CD169+ Macrophages and cDC1

10.3390/vaccines9010056

Saved in:
Bibliographic Details
Main Authors: Grabowska, Joanna, Stolk, Dorian A., Nijen Twilhaar, M.K., Ambrosini, Martino, Storm, Gert, van der Vliet, Hans J., de Gruijl, Tanja D., Kooyk, Y., den Haan, Joke M. M.
Other Authors: SURGERY
Format: Article
Published: MDPI AG 2022
Subjects:
Alpha galactosylceramide
Anti-tumor
CD169 macrophage
CDC1
Ganglioside GM3
Invariant natural killer T cell
Liposomes
Vaccination
Online Access:https://scholarbank.nus.edu.sg/handle/10635/233798
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore

Internet

https://scholarbank.nus.edu.sg/handle/10635/233798

Similar Items